In 2012, Prensner et al. [5] reported the discovery of a novel prostate cancer lncRNA, PCAT-1, which alternately demonstrates either repression by PRC2 or an active role in promoting cell proliferation through transcriptional regulation of target genes. The gene discussed is PCAT1; the disease is Familial prostate cancer.